Diagnostics (HCV)

RIBA Testing Not Effective for Screening Anti-HCV Positive Patients

Published in Hepatitis Weekly, April 13th, 1998

Researchers in Denmark found that recombinant immunoblot assay (RIBA) was not particularly helpful in detecting hepatitis C RNA (HCV-RNA) in anti-HCV positive patients.

Based on their finding, they now test all anti-HCV positive cases for HCV-RNA using HCV-PCR (polymerase chain reaction).

Between May 1991 and August 1996, H.B. Krarup and colleagues at the Aalborg Hospital tested more than 4,300 anti-HCV (enzyme immunoassay [EIA]) positive patients using either RIBA-2 or RIBA-3, and HCV-PCR.

Although they found RIBA-3 produced fewer indeterminate results than RIBA-2 (5 percent compared to 9 percent), the trend was not statistically...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1998-04-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry